1. Home
  2. EVAX vs CNSP Comparison

EVAX vs CNSP Comparison

Compare EVAX & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • CNSP
  • Stock Information
  • Founded
  • EVAX 2008
  • CNSP 2017
  • Country
  • EVAX Denmark
  • CNSP United States
  • Employees
  • EVAX N/A
  • CNSP N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVAX Health Care
  • CNSP Health Care
  • Exchange
  • EVAX Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • EVAX 10.8M
  • CNSP 5.6M
  • IPO Year
  • EVAX 2021
  • CNSP 2019
  • Fundamental
  • Price
  • EVAX $2.37
  • CNSP $0.94
  • Analyst Decision
  • EVAX Strong Buy
  • CNSP Hold
  • Analyst Count
  • EVAX 2
  • CNSP 1
  • Target Price
  • EVAX $10.00
  • CNSP N/A
  • AVG Volume (30 Days)
  • EVAX 115.9K
  • CNSP 213.3K
  • Earning Date
  • EVAX 08-13-2025
  • CNSP 08-13-2025
  • Dividend Yield
  • EVAX N/A
  • CNSP N/A
  • EPS Growth
  • EVAX N/A
  • CNSP N/A
  • EPS
  • EVAX N/A
  • CNSP N/A
  • Revenue
  • EVAX $3,293,000.00
  • CNSP N/A
  • Revenue This Year
  • EVAX N/A
  • CNSP N/A
  • Revenue Next Year
  • EVAX N/A
  • CNSP N/A
  • P/E Ratio
  • EVAX N/A
  • CNSP N/A
  • Revenue Growth
  • EVAX 2555.64
  • CNSP N/A
  • 52 Week Low
  • EVAX $1.20
  • CNSP $0.73
  • 52 Week High
  • EVAX $17.75
  • CNSP $148.00
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 49.33
  • CNSP 47.19
  • Support Level
  • EVAX $2.35
  • CNSP $0.73
  • Resistance Level
  • EVAX $2.60
  • CNSP $1.03
  • Average True Range (ATR)
  • EVAX 0.27
  • CNSP 0.08
  • MACD
  • EVAX -0.04
  • CNSP 0.02
  • Stochastic Oscillator
  • EVAX 36.36
  • CNSP 56.67

About EVAX Evaxion Biotech

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: